Literature DB >> 32038960

Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.

Zhengqing Bao1,2,3, Yicong Du1,2,3, Yiming Yuan1,2,3,4, Yuze Zhu1,2,3,5, Cheng Qian1,2,3, Yonghao Zhan1,2,3, Dong Fang1,2,3,4, Gengyan Xiong1,2,3, Lei Zhang1,2,3, Xuesong Li1,2,3, Liqun Zhou1,2,3.   

Abstract

BACKGROUND: Studies regarding the prevalence and factors associated with severe pre-operative chronic kidney disease (CKD) in upper tract urinary carcinoma (UTUC) patients were rare due to the low prevalence of UTUC. We conducted the present study to investigate the prevalence, clinicopathological features, and prognosis in UTUC patients with severe preoperative CKD.
METHODS: The study included 731 patients with UTUC treated with radical nephroureterectomy (RNU) in a large Chinese center. Estimated glomerular filtration rate (eGFR) was calculated by re-expressed Modification of Diet in Renal Disease (MDRD) formulas for the Chinese population. Severe preoperative CKD was defined as CKD stage 4-5 (eGFR <30 mL/min). Relationships of CKD stage 4-5 with clinicopathological characteristics, overall survival (OS), cancer-specific survival (CSS), contralateral recurrence-free survival and intravesical recurrence (IVR)-free survival were analyzed.
RESULTS: A total of 73 (10.0%) patients presented severe preoperative CKD in this cohort. Multivariate logistic analysis indicated that female gender (OR =1.791; 95% CI: 1.018-3.150; P=0.043), lower BMI (OR =0.452; 95% CI: 0.262-0.778; P=0.004), concomitant bladder tumor (OR =2.944; 95% CI: 1.360-6.373; P=0.006), lower pathological T stage (OR =0.578; 95% CI: 0.339-0.984; P=0.043), tumor necrosis (OR =2.764; 95% CI: 1.411-5.416; P=0.003), and exposure of aristolochic acid (AA) (OR =3.115; 95% CI: 1.536-6.316; P=0.002) were significantly related to severe CKD. Multivariate Cox's regression analysis showed that severe preoperative CKD was significantly associated with worse OS (HR =1.840; 95% CI: 1.150-2.944; P=0.011) and worse contralateral recurrence-free survival (HR =3.269; 95% CI: 1.607-6.650; P=0.001), while no statistical difference in terms of CSS or IVR-free survival were noticed.
CONCLUSIONS: Female gender, lower BMI, concomitant bladder tumor, lower pathological T stage, exposure of AA, and tumor necrosis were independently associated with severe preoperative CKD in UTUC patients. UTUC patients with severe preoperative CKD possess worse OS and higher possibility of contralateral upper urinary tract recurrence. 2019 Translational Andrology and Urology. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease (CKD); contralateral recurrence-free survival; overall survival (OS); radical nephroureterectomy (RNU); upper tract urinary carcinoma (UTUC)

Year:  2019        PMID: 32038960      PMCID: PMC6987590          DOI: 10.21037/tau.2019.11.19

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  26 in total

1.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

Authors:  Ying-Chun Ma; Li Zuo; Jiang-Hua Chen; Qiong Luo; Xue-Qing Yu; Ying Li; Jin-Sheng Xu; Song-Min Huang; Li-Ning Wang; Wen Huang; Mei Wang; Guo-Bin Xu; Hai-Yan Wang
Journal:  J Am Soc Nephrol       Date:  2006-09-20       Impact factor: 10.121

Review 2.  A systematic review of the possible carcinogenic role of the aristolochic acid.

Authors:  Tivadar Bara; Simona Gurzu; Haruhiko Sugimura; Tivadar Bara; Marius Alexandru Beleaua; Ioan Jung
Journal:  Rom J Morphol Embryol       Date:  2017       Impact factor: 1.033

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

4.  Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Authors:  Jay D Raman; Casey K Ng; Stephen A Boorjian; E Darracott Vaughan; R Ernest Sosa; Douglas S Scherr
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

5.  Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?

Authors:  Gordon A Brown; J Erik Busby; Christopher G Wood; Louis L Pisters; Colin P N Dinney; David A Swanson; H Barton Grossman; Curtis A Pettaway; Mark F Munsell; Ashish M Kamat; Surena F Matin
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

6.  Metachronous multifocal development of urothelial cancers by intraluminal seeding.

Authors:  T Habuchi; R Takahashi; H Yamada; Y Kakehi; T Sugiyama; O Yoshida
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

7.  Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.

Authors:  Hideaki Miyake; Isao Hara; Sadao Kamidono; Hiroshi Eto
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

Review 8.  Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.

Authors:  V Stefanovic; M Polenakovic; D Toncheva
Journal:  Pathol Biol (Paris)       Date:  2009-11-05

9.  The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.

Authors:  Chih-Hsiung Kang; Tsan-Jung Yu; Hwei-Ho Hsieh; Joseph W Yang; Kenneth Shu; Chao-Cheng Huang; Po-Huang Chiang; Yow-Ling Shiue
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

Review 10.  Diagnostic dilemmas in patients with upper tract urothelial carcinoma.

Authors:  Joyce Baard; Daniel M de Bruin; Patricia J Zondervan; Guido Kamphuis; Jean de la Rosette; M Pilar Laguna
Journal:  Nat Rev Urol       Date:  2016-12-13       Impact factor: 14.432

View more
  3 in total

1.  Reduced Preoperative Glomerular Filtration Rate Is Associated With Adverse Postoperative Oncological Prognosis in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Shijie Li; Xiaonan Chen; Jianyi Zheng; Xuefeng Liu
Journal:  Front Surg       Date:  2022-04-25

2.  Outcomes of arteriovenous access among cancer patients requiring chronic haemodialysis.

Authors:  Seonjeong Jeong; Hyunwook Kwon; Jai Won Chang; Youngjin Han; Tae-Won Kwon; Yong-Pil Cho
Journal:  BMC Nephrol       Date:  2020-07-23       Impact factor: 2.388

3.  The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years.

Authors:  Chunru Xu; Changwei Yuan; Cuijian Zhang; Dong Fang; Yanfei Yu; Xiang Wang; Zhihua Li; Yan Wang; Qi Tang; Gengyan Xiong; Lei Zhang; Zhisong He; Jian Lin; Liqun Zhou; Xuesong Li
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.